AAPS member leaders have redesigned the annual meeting to address user needs. Members told AAPS that they are now responsible for learning and understanding more about the cross-pollination of the biomolecular and chemical entities. AAPS has responded to this need by redesigning every aspect of the annual meeting, to create a more impactful format, PharmSci 360.
This new meeting is designed to:
- Increase collaboration between small molecule and biologics-focused scientists
- Provide conference attendees a meaningful and engaging learning experience
- Focus on new research and accomplish business objectives
- Provide training on new hot topics
- Take advantage of the great strength of the AAPS community: cross-discipline learning experiences
Every part of the new event is designed to build up scientific knowledge and collaboration. There will be sessions grouped into tracks and split into chemical and biomolecule areas.
The scientific program will be grouped into five tracks:
- Preclinical including Discovery
- Clinical Pharmacology
- Manufacturing & Bioprocessing
- Formulation & Quality
Within each track, the program will offer parallel tracks covering the chemical entity and biomolecule areas, each offering scientific depth through symposia, keynote talks, and rapid-fire presentations.
Each of those tracks will be split into two disciplines, and attendees will be able to follow a thematic topic from end to end through the different tracks, to gain breadth in that area.
The final piece of the programming will be the rapid-fire presentations.